A tumor-associated β1 integrin mutation that abrogates epithelial differentiation control
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
SCC4 human keratinocytes are derived from a squamous cell carcinoma of the tongue and undergo very little spontaneous differentiation. Introduction of a wild-type β1 integrin subunit into SCC4 cells stimulates differentiation, suggesting either that the cells have a defect in the integrin signaling pathways that control differentiation or that the β1 subunit itself is defective. Here we describe a heterozygous mutation in the SCC4 β1 subunit. The mutation, T188I, maps to the I-like domain. It results in constitutive activation of ligand binding, irrespective of the partner α subunit, in solid phase assays with recombinant protein and in living cells. The mutation promotes cell spreading, but not proliferation, motility, or invasiveness. It results in sustained activation of Erk MAPK independent of cell spreading. When introduced into SCC4 keratinocytes, the wild-type β1 integrin stimulates differentiation, whereas the mutant is inactive. Activation of β1 integrins in normal keratinocytes also suppresses differentiation. These results establish, for the first time, mutation as a mechanism by which integrins can contribute to neoplasia, because the degree of differentiation in epithelial cancers is inversely correlated with prognosis. They also provide new insights into how integrins regulate keratinocyte differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of integrins in regulating epidermal adhesion, growth and differentiation
Watt, F. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf399 · Cited by 647
Self-citation
Cited by
Extracellular-matrix tethering regulates stem-cell fate
Trappmann, B., Gautrot, J. E., Connelly, J. T., Strange, D. G. T., Li, Y., Oyen, M. L., Cohen Stuart, M. A., Boehm, H., Li, B., Vogel, V., et al. (2012) · Nature Materials · doi:10.1038/nmat3339 · Cited by 1,568
Self-citationModulating the stem cell niche for tissue regeneration
Lane, S. W., Williams, D. A., & Watt, F. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2978 · Cited by 615
Self-citationCell-Extracellular Matrix Interactions in Normal and Diseased Skin
Watt, F. M., & Fujiwara, H. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005124 · Cited by 384
“It results in constitutive activation of ligand binding and sustained activation of Erk MAPK (Evans et al. 2003).”
BackgroundInfluentialSelf-citationSignalling via integrins: Implications for cell survival and anticancer strategies
Hehlgans, S., Haase, M., & Cordes, N. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.09.001 · Cited by 373
Contribution of stem cells and differentiated cells to epidermal tumours
Owens, D. M., & Watt, F. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1096 · Cited by 346
Self-citationCell Adhesion Molecules: Role and Clinical Significance in Cancer
Makrilia, N., Kollias, A., Manolopoulos, L., & Syrigos, K. (2009) · Cancer Investigation · doi:10.3109/07357900902769749 · Cited by 330
Mutational drivers of cancer cell migration and invasion
Novikov, N. M., Zolotaryova, S. Y., Gautreau, A. M., & Denisov, E. V. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01149-0 · Cited by 302
MYC in mammalian epidermis: how can an oncogene stimulate differentiation?
Watt, F. M., Frye, M., & Benitah, S. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2328 · Cited by 157
“A specific example is that if a tumour has acquired an activating integrin mutatio”
Self-citationKindlin-1 controls Wnt and TGF-β availability to regulate cutaneous stem cell proliferation
Rognoni, E., Widmaier, M., Jakobson, M., Ruppert, R., Ussar, S., Katsougkri, D., Böttcher, R. T., Lai-Cheong, J. E., Rifkin, D. B., McGrath, J. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3490 · Cited by 140
Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate
Chermnykh, E., Kalabusheva, E., & Vorotelyak, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041003 · Cited by 95
“In culture, β1-integrin activation suppresses the terminal differentiation of keratinocytes [116].”
BackgroundReuter, J. A., Ortiz-Urda, S., Kretz, M., Garcia, J., Scholl, F. A., Pasmooij, A. M. G., Cassarino, D., Chang, H. Y., & Khavari, P. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.002 · Cited by 88
“b1 integrin activity is known to modulate keratinocyte differentiation in culture (Evans et al., 2003) and ectopic expression of specific b1 integrin receptors enhances chemical-induced transformation of murine epidermis (Janes and Watt, 2006).”
Vigilante, A., Laddach, A., Moens, N., Meleckyte, R., Leha, A., Ghahramani, A., Culley, O. J., Kathuria, A., Hurling, C., Vickers, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.094 · Cited by 34
“The identification of nsSNVs in integrin genes is of particular interest, because integrins are highly polymorphic and some of the previously reported nsSNVs alter adhesive functions of cancer cells (Ferreira et al., 2009; Evans et al., 2003).”
BackgroundSelf-citationChoi, H.-R., Shin, J.-W., Na, J.-I., Nam, K.-M., Lee, H.-S., & Park, K.-C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/359740 · Cited by 9
“Furthermore, activation of β1 integrin is reported to decrease terminal differentiation of cells [24].”
Background
Metadata
- Authors
- Evans, R. D., Perkins, V. C., Henry, A., Stephens, P. E., Robinson, M. K., & Watt, F. M.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2003-02-10
- Volume
- 160
- Issue
- 4
- Pages
- 589-596
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2051486518
- Cited by
- 73
- References
- 1
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.